Sources

Abebe W. (2002). Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther, 27, 391-401.

Amsterdam J et al. (2009). A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharm, 29, 378-382.

De la Torre, Morin F, Sanchez et al. (2001). Clinical cross-reactivity between Artemisia vulgaris and Marticaria recutita (chamomile). J Invesig Allergo Clin Immunol, 11, 118-122.

Hamilton M. (1959). The assessment of anxiety status by rating. Br J Med Psychol, 32:, 50-55.

Jarrahi M et al. 2009). Evaluation of topical Matricaria chamomilla extract on linear incisional wound healing in albino rats. Nat Pro Res, 24, 697-702.

Mann C, Staba E. (1986). The chemistry, pharmacology, and commercial formulations of Chamomile. Herbs, spices and medicinal plants: Recent advances in botany and horticulture and pharmacology. Oryx Press: Phoenix, 235-280.

Mao J et al. (2007). Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med, 15, 21-29.

McKay D, Blumberg J. (2006). A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother. Res, 20, 519-530.

Miller LG. (1998). Herbal medicinal: selected clinical considerations focusing on known or potential drug herb interactions. Arch Intern Med, 158, 2200-2211.

Natural Standard Monograph. ( 2010). Chamomile (Matricaria recutita, Chamaemelum Nobile). Nat Stan Prof Mono 1-33.

NCCAM. Herbs at a glance: chamomile. (2010). National Centre for Complementary and Alternative Medicine: U.S. Department of Health and Human Services. 18 Nov 2010..

O’Hara M et al. (1998). A review of 12 commonly used medicinal herbs. Arch Fam Med, 7, 523-536.

O’Connor K et al. (1999). Physiological distress and adaptational problems associated with discontinuation of benzodiazepines. Addict Behav, 24, 537-541.

Orav, A et al. (2010). Content and composition of the essential oil of Chamomilla recutita (L.) Rauschert from some European countries. Nat Pro Res, 24, 48- 55.

Periera F, Santos R, Periera A.(1997). Contact dermatitis from chamomile tea. Con Derm, 36, 307.

Reider N et al. (2000). Anaphylaxis to camomile: clinical features and allergen cross-reactivity. Clin Exp Allergy, 30,1436-1443. 22: 56-57.

Ross SMR. (2008). Chamomile: a spoonful of medicine. Holist Nurse Pract, 22, 56-57.

Segal R, Pilote L. (2006). Warfarin interaction with Matricaria chamomile. CMAJ, 174, 1281-
1282.

Szoke E et al. (2004). New terpenoids in cultivated and wild chamomile (in vivo and in vitro). J
Chroma B, 800, 231-238.

Thorne Research Inc. (2008). Matricaria chamomilla (German chamomile). Alt Med Rev, 13, 58-
62.